AU7388700A - Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene - Google Patents

Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene

Info

Publication number
AU7388700A
AU7388700A AU73887/00A AU7388700A AU7388700A AU 7388700 A AU7388700 A AU 7388700A AU 73887/00 A AU73887/00 A AU 73887/00A AU 7388700 A AU7388700 A AU 7388700A AU 7388700 A AU7388700 A AU 7388700A
Authority
AU
Australia
Prior art keywords
polymorphisms
gene
drug target
hydroxytryptamine receptor
isogenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73887/00A
Inventor
R. Rex Denton
Stefanie E. Kliem
Krishnan Nandabalan
Joel Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU7388700A publication Critical patent/AU7388700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Addiction (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU73887/00A 1999-08-06 2000-08-01 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene Abandoned AU7388700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14771199P 1999-08-06 1999-08-06
US60147711 1999-08-06
PCT/US2000/040519 WO2001010884A1 (en) 1999-08-06 2000-08-01 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene

Publications (1)

Publication Number Publication Date
AU7388700A true AU7388700A (en) 2001-03-05

Family

ID=22522622

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73887/00A Abandoned AU7388700A (en) 1999-08-06 2000-08-01 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene

Country Status (4)

Country Link
EP (1) EP1208112A1 (en)
JP (1) JP2003506070A (en)
AU (1) AU7388700A (en)
WO (1) WO2001010884A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004537311A (en) * 2001-07-16 2004-12-16 プライス ファンデーション リミテッド Genes and SNPs associated with eating disorders
WO2005060675A2 (en) * 2003-12-19 2005-07-07 Philadelphia Health And Education Corporation(D/B/A Drexel University College Of Medicine (Ducom)) Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto
WO2007070252A2 (en) * 2005-11-30 2007-06-21 The University Of North Carolina At Chapel Hill Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same

Also Published As

Publication number Publication date
WO2001010884A1 (en) 2001-02-15
JP2003506070A (en) 2003-02-18
EP1208112A1 (en) 2002-05-29

Similar Documents

Publication Publication Date Title
AU7445900A (en) Novel hemopoietin receptor protein, nr12
AU3178200A (en) Genetic analysis
AU7119400A (en) Single nucleotide polymorphisms in genes
AU1922801A (en) Genomic polymorphism for predicting therapeutic response
AU6492400A (en) Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
AU2000263446A1 (en) Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene
AU7388700A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
EP1144631A3 (en) Insulin-synthesis genes
AU2001213316A8 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU2258601A (en) Ibd-related polymorphisms
AU6755300A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU1081401A (en) Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU1570701A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1e gene
AU7994500A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene
AU1773501A (en) Human single nucleotide polymorphisms
AU2000236029A1 (en) Receptor isogenes: polymorphisms in the tissue necrosis factor receptor
AU2001213316A1 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU2001288564A1 (en) 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
AU1338901A (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene
AU3269401A (en) Simultaneous hybridization/priming for snp analysis
AU6904100A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene
AU4808200A (en) Dna balls
AU1404901A (en) Cd36 polymorphisms

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase